Body One Valuation
MLONE Stock | EUR 0.32 0.00 0.00% |
Body One seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Body One SA from analyzing the firm fundamentals such as return on equity of 0.34, and Profit Margin of 0.05 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Body One's price fluctuation is out of control at this time. Calculation of the real value of Body One SA is based on 3 months time horizon. Increasing Body One's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Body One's intrinsic value may or may not be the same as its current market price of 0.32, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.32 | Real 0.25 | Hype 0.32 |
The intrinsic value of Body One's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Body One's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Body One SA helps investors to forecast how Body stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Body One more accurately as focusing exclusively on Body One's fundamentals will not take into account other important factors: Body One Total Value Analysis
Body One SA is now projected to have takeover price of 2.05 M with market capitalization of 1.47 M, debt of 5 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Body One fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
2.05 M | 1.47 M | 5 M |
Body One Investor Information
The company recorded a loss per share of 0.04. Body One SA had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Body One's historical financial statements, Body One SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Body One Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Body One has an asset utilization ratio of 127.02 percent. This connotes that the Company is making 1.27 for each dollar of assets. An increasing asset utilization means that Body One SA is more efficient with each dollar of assets it utilizes for everyday operations.Body One Profitability Analysis
The company reported the revenue of 11.43 M. Net Income was 590.54 K with profit before overhead, payroll, taxes, and interest of 3.15 M.About Body One Valuation
The stock valuation mechanism determines Body One's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Body One SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Body One. We calculate exposure to Body One's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Body One's related companies.It offers bottoms, lingerie, shorts, trousers, bikinis, and sportswear. The company was founded in 1998 and is based in Pantin, France. BODY ONE operates under Apparel Manufacturing classification in France and is traded on Paris Stock Exchange.
8 Steps to conduct Body One's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Body One's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Body One's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Body One's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Body One's revenue streams: Identify Body One's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Body One's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Body One's growth potential: Evaluate Body One's management, business model, and growth potential.
- Determine Body One's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Body One's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Body Stock Analysis
When running Body One's price analysis, check to measure Body One's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Body One is operating at the current time. Most of Body One's value examination focuses on studying past and present price action to predict the probability of Body One's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Body One's price. Additionally, you may evaluate how the addition of Body One to your portfolios can decrease your overall portfolio volatility.